Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 47621301000001114 | Reyataz (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 47621401000001118 | Reyataz | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Reyataz | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Reyataz 150mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) | Is a | True | Reyataz | Inferred relationship | Existential restriction modifier | |
| Reyataz 200mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) | Is a | True | Reyataz | Inferred relationship | Existential restriction modifier | |
| Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) | Is a | True | Reyataz | Inferred relationship | Existential restriction modifier | |
| Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) | Is a | True | Reyataz | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR